<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Cerebrovascular <z:mp ids='MP_0005048'>thrombosis</z:mp> is a major source of morbidity and mortality after surgery, but thromboprophylaxis in this setting is limited because of the formidable risk of perioperative <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Thrombolytics (eg, tissue-type plasminogen activator [tPA]) cannot be used prophylactically in this high-risk setting because of their short duration of action and risk of causing <z:mp ids='MP_0001914'>hemorrhage</z:mp> and central <z:mp ids='MP_0008912'>nervous</z:mp> system damage </plain></SENT>
<SENT sid="2" pm="."><plain>We found that coupling tPA to carrier red blood cells (RBCs) prolongs and localizes tPA activity within the bloodstream and converts it into a thromboprophylactic agent, RBC/tPA </plain></SENT>
<SENT sid="3" pm="."><plain>To evaluate the utility of this new approach for preventing cerebrovascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, we examined the effect of RBC/tPA in animal models of cerebrovascular <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS AND RESULTS: Preformed fibrin microemboli were injected into the middle carotid artery of mice, occluding downstream perfusion and causing severe infarction and 50% mortality within 48 hours </plain></SENT>
<SENT sid="5" pm="."><plain>Preinjected RBC/tPA rapidly lysed nascent cerebral thromboemboli, providing rapid, durable reperfusion and reducing morbidity and mortality </plain></SENT>
<SENT sid="6" pm="."><plain>These beneficial effects were not achieved by preinjection of tPA, even at a 10-fold higher dose, which increased mortality from 50% to 90% by 10 hours after embolization </plain></SENT>
<SENT sid="7" pm="."><plain>RBC/tPA injected 10 minutes after tail <z:mpath ids='MPATH_686'>amputation</z:mpath> to simulate postsurgical hemostasis did not cause <z:mp ids='MP_0001914'>bleeding</z:mp> from the wound, whereas soluble tPA caused profuse <z:mp ids='MP_0001914'>bleeding</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>RBC/tPA neither aggravated brain damage caused by focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in a filament model of middle carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> nor caused postthrombotic <z:mp ids='MP_0001914'>hemorrhage</z:mp> in hypertensive rats </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These results suggest a potential RBC/tPA utility as thromboprophylaxis in patients who are at risk for <z:hpo ids='HP_0011009'>acute</z:hpo> cerebrovascular <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> </plain></SENT>
</text></document>